Data Safety and Monitoring Board - Revision history

Lawrence: /* Conclusion */

2025-06-03T21:07:56Z

Conclusion

← Older revision		Revision as of 21:07, 3 June 2025
Line 12:		Line 12:

	==== 2. Ensuring Scientific Integrity ====		==== 2. Ensuring Scientific Integrity ====
	* Monitors data quality, protocol adherence, and statistical analysis to maintain trial credibility.		* Monitors data quality, protocol adherence, and statistical [[analysis]] to maintain trial credibility.
	* Prevents bias or undue influence from investigators or sponsors.		* Prevents bias or undue influence from investigators or sponsors.

Line 21:		Line 21:
	** Stop early for efficacy (if results are overwhelmingly positive)		** Stop early for efficacy (if results are overwhelmingly positive)
	** Stop early for futility (if the intervention is unlikely to show benefit)		** Stop early for futility (if the intervention is unlikely to show benefit)
	** Modify the trial design (e.g., sample size adjustment, adaptive randomization)		** Modify the trial design (e.g., [[sample size]] adjustment, adaptive [[randomization]])

	==== 4. Maintaining Ethical Oversight ====		==== 4. Maintaining Ethical Oversight ====
	* Ensures the trial maintains '''equipoise''' (genuine uncertainty about treatment benefit).		* Ensures the trial maintains '''[[equipoise]]''' (genuine uncertainty about treatment benefit).
	* Upholds informed consent principles by ensuring participants are not exposed to unnecessary risk.		* Upholds [[informed consent]] principles by ensuring participants are not exposed to unnecessary risk.

	==== 5. Preventing Conflicts of Interest ====		==== 5. Preventing Conflicts of Interest ====
Line 33:		Line 33:
	==== 6. Providing Recommendations to Trial Sponsors and Investigators ====		==== 6. Providing Recommendations to Trial Sponsors and Investigators ====
	* Issues formal recommendations on continuation, modification, or termination of the trial.		* Issues formal recommendations on continuation, modification, or termination of the trial.
	* Communicates findings to ethics committees, regulatory agencies, and funding bodies.		* Communicates findings to [[ethics]] committees, regulatory agencies, and funding bodies.

	=== Conclusion ===		=== Conclusion ===

	A DSMB plays a critical role in safeguarding participants, ensuring trial integrity, and guiding ethical decision-making in an RCT.		A DSMB plays a critical role in safeguarding participants, ensuring trial integrity, and guiding ethical decision-making in an RCT.
			----

			=== Bibliography ===

			# Ellenberg SS, Fleming TR, DeMets DL. Data Monitoring Committees in Clinical Trials: A Practical Perspective. Wiley; 2002.
			# FDA. Guidance for Clinical Trial Sponsors: Establishment and Operation of Clinical Trial Data Monitoring Committees. U.S. Food and Drug Administration; 2006. Available from: https://www.fda.gov/media/75398/download
			# DAMOCLES Study Group. A proposed charter for clinical trial data monitoring committees: helping them to do their job well. ''The Lancet''. 2005;365(9460):711–722.
			# DeMets DL, Califf RM, Freedman B. Data monitoring in clinical trials: expectations and responsibilities. ''Annals of Internal Medicine''. 2004;140(5):374–375.
			# Wittes J. Data monitoring committees: helping to keep an eye on the data. ''Journal of Clinical Oncology''. 2006;24(19):3189–3192.

			----
			''Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.''

Lawrence at 14:20, 27 March 2025

2025-03-27T14:20:31Z

← Older revision		Revision as of 14:20, 27 March 2025
Line 38:		Line 38:

	A DSMB plays a critical role in safeguarding participants, ensuring trial integrity, and guiding ethical decision-making in an RCT.		A DSMB plays a critical role in safeguarding participants, ensuring trial integrity, and guiding ethical decision-making in an RCT.

	~~''Would you like guidance on DSMB setup or reporting procedures?''~~

Lawrence: Created page with "== Data and Safety Monitoring Board (DSMB) == === Role of a Data and Safety Monitoring Board in a Randomized Trial === A '''Data and Safety Monitoring Board (DSMB)''' is an independent committee responsible for ensuring participant safety, trial integrity, and scientific validity in a randomized controlled trial (RCT). === Key Roles of a DSMB === ==== 1. Protecting Participant Safety ==== * Regularly reviews adverse events (AEs), serious adverse events (SAEs), and mo..."

2025-03-24T20:44:07Z

Created page with "== Data and Safety Monitoring Board (DSMB) == === Role of a Data and Safety Monitoring Board in a Randomized Trial === A '''Data and Safety Monitoring Board (DSMB)''' is an independent committee responsible for ensuring participant safety, trial integrity, and scientific validity in a randomized controlled trial (RCT). === Key Roles of a DSMB === ==== 1. Protecting Participant Safety ==== * Regularly reviews adverse events (AEs), serious adverse events (SAEs), and mo..."

New page

== Data and Safety Monitoring Board (DSMB) ==

=== Role of a Data and Safety Monitoring Board in a Randomized Trial ===

A '''Data and Safety Monitoring Board (DSMB)''' is an independent committee responsible for ensuring participant safety, trial integrity, and scientific validity in a randomized controlled trial (RCT).

=== Key Roles of a DSMB ===

==== 1. Protecting Participant Safety ====
* Regularly reviews adverse events (AEs), serious adverse events (SAEs), and mortality data.
* Recommends trial modifications or termination if there is excessive harm or unexpected safety concerns.

==== 2. Ensuring Scientific Integrity ====
* Monitors data quality, protocol adherence, and statistical analysis to maintain trial credibility.
* Prevents bias or undue influence from investigators or sponsors.

==== 3. Conducting Interim Analyses ====
* Evaluates pre-specified endpoints at scheduled intervals.
* Assesses whether the trial should:
** Continue as planned (if no significant concerns)
** Stop early for efficacy (if results are overwhelmingly positive)
** Stop early for futility (if the intervention is unlikely to show benefit)
** Modify the trial design (e.g., sample size adjustment, adaptive randomization)

==== 4. Maintaining Ethical Oversight ====
* Ensures the trial maintains '''equipoise''' (genuine uncertainty about treatment benefit).
* Upholds informed consent principles by ensuring participants are not exposed to unnecessary risk.

==== 5. Preventing Conflicts of Interest ====
* DSMB members are independent of the trial investigators and sponsors.
* Their decisions are confidential and data-driven, preventing premature disclosure of results.

==== 6. Providing Recommendations to Trial Sponsors and Investigators ====
* Issues formal recommendations on continuation, modification, or termination of the trial.
* Communicates findings to ethics committees, regulatory agencies, and funding bodies.

=== Conclusion ===

A DSMB plays a critical role in safeguarding participants, ensuring trial integrity, and guiding ethical decision-making in an RCT.

''Would you like guidance on DSMB setup or reporting procedures?''